Precision Business Insights
Portfolio

 

Research Reports

North America Hemostasis Diagnostics Market: Market Estimation, Dynamics, Country Share, Trends, Competitor Analysis 2012 to 2016 and Forecast 2017 to 2023

North America Hemostasis Diagnostics Market: By Product Type (Systems, Consumables, Point-of-Care Testing Devices), By Test Type (Fibrinogen Test, Activated Clotting Time, Platelet Function, Prothrombin Time, Heparin & Protamine Dose-Response Test For ACT, Activated Partial Thromboplastin Time, Anti-Factor Xa, Other Coagulation Tests), By Technology (Optical, Mechanical, Electrochemical, Others), By End-User (Hospitals, Clinics, Diagnostic Centres, Others (POC)), and Geography – Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023

 

Market Outline: North America Hemostasis Diagnostics Market

Hemostasis diagnostics are the devices used to determine the hemostatic defects, which cause excessive bleeding. Hemostasis is defined as the stopping or slowing the blood flow from damaged blood vessel. During the hemostasis, blood changes from liquid state to the gelatinous state. Hemostasis maintained in the body by three mechanisms namely, blood coagulation, platelet plug formation, and vasoconstriction. Hemostasis diagnostics may help to predict the cause of bleeding during surgery by identifying the hemostatic defects in patients. Different types of tests such as prothrombin test, activated clotting time, platelet function, and other coagulation tests are carried to identify the hemostasis defects.

 

Market Dynamics: North America Hemostasis Diagnostics Market

Increase in the prevalence of hemophilia disease in U.S. and Canada (according to Canadian Hemophilia Society, approximately 35,000 Canadians are having an inherited bleeding disorder gene), rise in number of surgeries, technological advancements in the hemostasis diagnostics such as accurate results in less time, and rise in R&D investment for novel tests and devices innovation are expected to boost the hemostasis diagnostics market. However, high cost of advanced hemostasis products, and stringent regulations for the test approvals are expected to hamper the growth of hemostasis diagnostics market.

 

Market Scope: North America Hemostasis Diagnostics Market

Hemostasis diagnostics market is segmented on the basis of product type, test type, technology, and end user

Based on the product type, market is segmented into the following:

  • Systems
  • Consumables
  • Point-of-Care Testing Devices

Based on the test type, market is segmented into the following:

  • Fibrinogen Test
  • Activated Clotting Time
  • Platelet Function
  • Prothrombin Time
  • Heparin & Protamine Dose-Response Test For ACT
  • Activated Partial Thromboplastin Time
  • Anti-Factor Xa
  • Other Coagulation Tests

Based on the technology, market is segmented into the following:

  • Optical
  • Mechanical
  • Electrochemical
  • Others

Based on the end user, market is segmented into the following:

  • Hospitals
  • Clinics
  • Diagnostic Centres
  • Others (POC)

 

 Regional Analysis: North America Hemostasis Diagnostics Market

Geographically, North America hemostasis diagnostics market has been segmented into U.S. and Canada. U.S. hemostasis diagnostics market is projected to grow at a significant CAGR owing to increase in the prevalence of hemophilia disease. For instance, according to Centre for Disease Control and Prevention 2015, approximately 20,000 people are suffering from hemophilia in U.S., increase in the R&D activities for the development of newer tests, and FDA clearance for the newer diagnostics tests are anticipated to fuel the market. Canada hemostasis diagnostics market expected to grow at notable rate due to increase in the prevalence of hemophilia disease, rise in prevalence & incidence of various cardiovascular diseases and expansion of business by the market players in Canada are expected to propel the market. For instance, in February 2012, Roche collaborated with Technoclone to expand the reagent portfolio for coagulation diagnostics in US and Canada.

 

Competition Assessment: North America Hemostasis Diagnostics Market

Some of the players in the North America hemostasis diagnostics market include:

  • Hoffmann-La Roche Ltd. (Switzerland)
  • Sysmex Corporation (Japan)
  • Abbott Laboratories (U.S.)
  • Alere Inc.  (U.S.)
  • Nihon Kohden Corporation (Japan)
  • Siemens Healthineers (Germany)
  • Danaher Corporation (U.S.)
  • Instrumentation Laboratory (U.S.)
  • Grifols S.A (Spain)
  • Beckman Coulter, Inc. (U.S.)

Notable Market Developments: North America Hemostasis Diagnostics Market

  • In August 2016, Siemens Healthiners launched Sysmex CS-2500, a mid-volume coagulation analyzer in the U.S.

 

 

Key Features of the Report:

  • The report provides granular level information about the market size, regional market share, and forecast from 2017-2023
  • The report covers in-detail insights about the competitor’s overview, key findings, and their key strategies
  • The report outlines drivers, restraints, challenges, and trends that are currently faced by the industry
  • The report tracks recent innovations, key developments and start-up’s details that are working in the industry
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • Hoffmann-La Roche Ltd. (Switzerland)
  • Sysmex Corporation (Japan)
  • Abbott Laboratories (U.S.)
  • Alere Inc.  (U.S.)
  • Nihon Kohden Corporation (Japan)
  • Siemens Healthineers (Germany)
  • Danaher Corporation (U.S.)
  • Instrumentation Laboratory (U.S.)
  • Grifols S.A (Spain)
  • Beckman Coulter, Inc. (U.S.)

A complementary 2hrs free facility through which report buyers can interact with our pool of experienced analysts for any report related queries, clarifications or additional data requirements

$ 2,000.00$ 6,900.00
Region North America
Clear selection

Select License Type

DatabankNorth America $ 2,000.00
spinner
Single UserNorth America $ 3,100.00
spinner
Multiple UserNorth America $ 4,600.00
spinner
Corporate UserNorth America $ 6,900.00
spinner
buy now spinner
FacebookTwitterLinkedinEmail

Our Clients

Testimonials